Master of Science in Chemical engineering. Employed since 2016 and is responsible for process development and production of antibodies for clinical studies. He has 25 years of experience from managing manufacturing of antibodies and other proteins for clinical use. Kristoffer has held numerous positions within CMC Biologics A/S (now AGC Biologics), DAKO A/S and Symphogen A/S. Born 1974.

Shareholding: 22,303 (whereof 7,177 in endowment insurance)

Conditional Employee Options: Option program 2023/2025: 24,000, Option program 2024/2026: 15,000, Option program 2025/2027: 7,000

/sites/bioinvent/files/bioinvert/investors/corporate-governance/management-team/krist.png Senior Vice President, Technical Operations Management Team Off